Skip to main content
. 2023 Nov 20;9(4):e003419. doi: 10.1136/rmdopen-2023-003419

Table 3.

Multinomial logistic regression analysis exploiting ORs-like to evaluate the predictive strength of the derived clusters on the overall outcomes of patients

ORs-like SE 95% CI P value
Monocyclic pattern
Base outcome
Polycyclic pattern
Cluster 1 Reference
Cluster 2 1.42 0.43 0.78 to 2.57 0.252
Cluster 3 0.66 0.31 0.27 to 1.64 0.373
Cluster 4 1.99 0.72 0.98 to 4.04 0.058
Chronic pattern
Cluster 1 Reference
Cluster 2 1.31 0.44 0.68 to 2.53 0.424
Cluster 3 0.40 0.24 0.12 to 1.31 0.132
Cluster 4 1.45 0.60 0.65 to 3.26 0.366
Mortality
Cluster 1 Reference
Cluster 2 4.56 3.73 0.92 to 22.63 0.064
Cluster 3 Not estimable
Cluster 4 11.03 9.10 2.19 to 55.60 0.004
χ2 = 21.68; p=0.010
Monocyclic pattern
Base outcome
Polycyclic pattern
Cluster 1 Reference
Cluster 2 1.46 0.45 0.80 to 2.67 0.220
Cluster 3 0.65 0.30 0.26 to 1.62 0.358
Cluster 4 2.00 0.73 0.98 to 4.07 0.057
Male sex 0.96 0.25 0.58 to 1.60 0.884
MAS 1.25 0.47 0.60 to 2.61 0.552
Chronic pattern
Cluster 1 Reference
Cluster 2 1.28 0.44 0.66 to 2.51 0.468
Cluster 3 0.41 0.25 0.13 to 1.35 0.144
Cluster 4 1.36 0.57 0.60 to 3.07 0.461
Male sex 1.67 0.49 0.94 to 2.97 0.079
MAS 1.21 0.52 0.52 to 2.82 0.652
Mortality
Cluster 1 Reference
Cluster 2 5.99 5.07 0.94 to 31.48 0.064
Cluster 3 Not estimable
Cluster 4 9.55 8.07 1.82 to 49.99 0.008
Male sex 2.36 1.29 0.80 to 6.91 0.118
MAS 5.99 3.52 1.89 to 18.95 0.002
χ2 = 37.48; p=0.001

Bold values are statistically significant results.

MAS, macrophage activation syndrome.